Can a simple scale help lung cancer patients stick to rehab?
NCT ID NCT06477302
First seen Jun 24, 2026 · Last updated Jun 27, 2026 · Updated 2 times
Summary
Researchers in Mexico are developing a questionnaire to measure how well lung cancer patients follow their respiratory rehabilitation program. The study will enroll 281 adults with lung cancer who are currently in rehab. Participants will fill out a 56-item scale, and the researchers will check if the tool is reliable and accurate. This is not a treatment study, but aims to create a useful measurement tool for doctors.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- What this could lead to
- If successful, this could provide doctors with a reliable tool to measure and improve how well lung cancer patients stick to their respiratory rehabilitation programs.
- What could go wrong
- This is an early-stage instrument development study, not a treatment trial. The scale may not prove accurate or useful in real-world settings.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for LUNG CANCER are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Instituto Nacional de Cancerologia
RECRUITINGMexico City, Mexico City, 14080, Mexico
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a simple CT scan catch lung cancer earlier in kuwait?
- Can a new drug combo revive Immunotherapy's power against resistant tumors?
- Seeing the fight: new imaging tracer may reveal how immune cells attack lung cancer
- Your Tumor's DNA might predict immunotherapy success
- Can a new PET tracer light up hidden cancers?
- Fellow veterans may hold the key to earlier lung cancer detection